Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Chronic Respiratory Disease is Scopus-indexed (Q2, CiteScore 4.4), WoS SCIE, DOAJ. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 1479-9723Verify ISSN ↗1479-9731Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 60 / 165 | 63rd | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2004–present, best quartile Q2, CiteScore 4.4.
Chronic Respiratory Disease is Q2 in Pulmonary and Respiratory Medicine (rank 60 of 165), by CiteScore 2025.
Chronic Respiratory Disease is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.4, which places it in quartile Q2 at the 63rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.811, quartile Q2, with an H-index of 58.
The publisher lists an article processing charge of about US$2,650 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Chronic Respiratory Disease is published by SAGE Publications Ltd. Its print ISSN is 1479-9723 and its online ISSN is 1479-9731.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Chronic Respiratory Disease has an h-index of 67 and a 2-year mean of 3.16 citations per paper (OpenAlex). Its Scopus CiteScore is 4.4, quartile Q2. On 2-year citations it ranks #23 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
Chronic Respiratory Disease published 50 papers in 2025; its busiest recent year was 2021 with 57. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2024–2026), authors are most often from United Kingdom (19.8%), China (19.6%) and Australia (10.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.